Drupal.behaviors.print = function(context) {window.print();window.close();}>
Scripps Study Highlights Protein Sulfenylation as Regulator of EGFR Activity, Potential Drug Target
December 16, 2011
Scripps Study Highlights Protein Sulfenylation as Regulator of EGFR Activity, Potential Drug Target
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
ASCO 2010 PGx Abstract Highlights
June 16, 2010 / Pharmacogenomics Reporter
GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build
May 18, 2012 / ProteoMonitor
Caprion Leading $21M Clinical Biomarker and Personalized Medicine Development Project
February 22, 2013 / ProteoMonitor
Targeted Mass Spec Slowly but Steadily Moving Toward Broader Commercial, Clinical Adoption
September 21, 2012 / ProteoMonitor
UCLA-Led Study IDs Kinase Signaling Feedback Loop Linked to Cell Death in Glucose-Dependent Cancers
June 29, 2012 / ProteoMonitor